insights_auto
Why is GALT down 2.31%?
Dive Deeperchevron_right
GALT:NASDAQ
Galectin Therapeutics Inc. Common Stock
$3.38
arrow_downward
-2.31%(-0.080) 1D
$3.38
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 10, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GALT...
Open
$3.44
High
$3.52
Low
$3.30
Mkt. cap
340.87M
Avg. vol.
211.91K
Volume
0.00
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
Open
$3.44
High
$3.52
Low
$3.30
Mkt. cap
340.87M
Avg. vol.
211.91K
Volume
0.00
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
News stories
From web sources and news partners
FXStreet
·
30 minutes ago
S&P 500: Higher yields weigh on equities – Deutsche Bank
Stocktwits
·
36 minutes ago
S&P 500, Nasdaq Futures Rise Premarket — CRWV, GPRO, SPCX, NVDA, NLST Stocks In Focus
The Motley Fool
·
20 minutes ago
Why the S&P 500 Could Be Heading for a Repeat of 2018
About Galectin Therapeutics Inc. Common Stock
CEO-
Employees9
Founded2000
HeadquartersNorcross, Georgia, United States
SectorHealth Care
IndustryBiotechnology
Websitegalectintherapeutics.com